Kalb Michael Wayne 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Kalb Michael Wayne
Executive Vice President & CFO
Transactions
- Award
Restricted Stock Units
2024-11-21+20,682→ 482,837 total→ Common Stock (20,682 underlying) - Award
Options to purchase common stock
2024-11-21+169,248→ 462,155 totalExercise: $21.12Exp: 2031-11-21→ Common Stock (169,248 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.